Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04703790 · ClinicalTrials.gov registry record

Acceptability of a COVID-19 Vaccine Among US Adults Over Two Time Periods

A clinical trial, sponsored by Columbia University.

Completed
Registry status
1,208
Enrollment target

NCT04703790 is a clinical trial that has completed, run by Columbia University. The registered enrollment target is 1,208 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04703790 has completed, sponsored by Columbia University.

COMPLETED
Registry status
1,208 participants
Enrollment target

Study Summary

The overall purpose of this study is to address the factors associated with an individual's personal willingness to get the vaccine and attitudes about potential public policy approaches to implementation of a Coronavirus Disease 2019 (COVID-19) vaccine. Additionally, to evaluate how these attitudes change over time. The 1200 participants will be recruited by Ipsos (Ipsos KnowledgePanel®) from their nationally representative panel to participate in a survey at Time 1 and 1 year later. The information collected will include demographics, health status, household composition, experiences with COVID-19, attitudes about vaccines in general, COVID-19 vaccine specific attitudes, willingness to get a COVID-19 vaccine acceptability, and attitudes regarding COVID-19 vaccine mandates. The investigators anticipate that those who live in urban areas and who are older, have greater knowledge of COVID-19, who have known someone who was hospitalized for COVID-19, and have generally positive attitudes about vaccines will be more willing to get a vaccine. The primary reasons for willingness will be personal safety and desire to return to normal activities. The investigators also anticipate that those who vary on socio-demographics (e.g., live in urban areas, have more liberal political views), have greater knowledge of COVID-19, who have known someone who was hospitalized for COVID- 19, and have generally positive attitudes about vaccines will be more supportive of mandatory vaccination strategies. The investigators anticipate that attitudes will change over time in response to the current status of the pandemic and of available data about the vaccine's efficacy and safety.

Trial Details

FieldValue
Enrollment Target 1,208 participants
Start Date 2021-04-07
Est. Completion 2022-02-18

Sponsor

Columbia University

958 total trials

What the Registry Record Tells You About NCT04703790

The ClinicalTrials.gov registry entry for NCT04703790 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,208 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT04703790 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04703790 about?

NCT04703790 is a clinical study titled "Acceptability of a COVID-19 Vaccine Among US Adults Over Two Time Periods". The overall purpose of this study is to address the factors associated with an individual's personal willingness to get the vaccine and attitudes about potential public policy approaches to implementation of a Coronavirus Disease 2019 (COVID-19) vaccine. Additionally, to evaluate how these attitudes...

What is the current status of trial NCT04703790?

This trial is currently completed. The enrollment target is 1,208 participants. The study started on 2021-04-07. Estimated completion is 2022-02-18.

Who is sponsoring clinical trial NCT04703790?

This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.